OpGen, Inc. (NASDAQ:OPGN – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $1.42 and traded as low as $0.00. OpGen shares last traded at $0.00, with a volume of 2 shares traded.
OpGen Price Performance
The stock’s 50-day moving average price is $1.42 and its two-hundred day moving average price is $2.96.
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Featured Stories
- Five stocks we like better than OpGen
- The 3 Best Retail Stocks to Shop for in August
- Archer’s Recent String of Victories Signals a New Phase of Growth
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- What to Know About Investing in Penny Stocks
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
